Richard Moss MD

Professor Emeritus, Stanford University

725 Welch RdPalo Alto, CA 94304
Phone+1 650-498-5710
Fax+1 650-723-5201

Dr. Moss is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Moss' full profile Already have an account?

Summary

Dr. Richard Moss is a pediatric pulmonologist based in Palo Alto, CA, with extensive experience in allergy and immunology. He completed his medical education and training at prestigious institutions, including a residency and fellowship at Stanford University. Dr. Moss has held numerous significant roles at Stanford, such as Chief and Professor of Pediatrics, along with his involvement at Lucile Packard Children's Hospital. He served as the Director of the Stanford Cystic Fibrosis Center and has contributed to the field through publications on challenging topics like antifungal drug development and cystic fibrosis treatments. Notably, he has participated in various clinical trials focused on cystic fibrosis and has received numerous accolades, including the Paul M Quinton Cystic Fibrosis Research Legacy Award in 2022.

Education & Training

Stanford UniversityPost-Doctoral Fellowship, 1980 - 1981
Stanford Health Care-Sponsored Stanford UniversityResidency, Allergy and Immunology, 1977 - 1981
Stanford Health Care-Sponsored Stanford UniversityFellowship, Allergy and Immunology, 1977 - 1979
McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 1975 - 1977
State University of New York Downstate Medical Center College of MedicineClass of 1975

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1977 - 2027
American Board of Allergy and Immunology Allergy & Immunology
American Board of Allergy and Immunology Diagnostic Laboratory Immunology
American Board of Pediatrics Pediatrics
National Board of Medical ExaminersMedical Examiners

Awards, Honors, & Recognition

Paul M Quinton Cystic Fibrosis Research Legacy Award Cystic Fibrosis Research Institute, 2022
William J Martin II Distinguished Achievement Award American Thoracic Society, 2018
Invited Plenary Speaker International Society of Human and Animal Mycology, Berlin Germany, 2012

Clinical Trials

Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have the R117H-CF Transmembrane Conductance Regulator (CFTR) Mutation (KONDUCT)
COMPLETED
PHASE3
Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF)
COMPLETED
PHASE3
Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients
COMPLETED
PHASE1, PHASE2

Publications & Presentations

PubMed

6 citations
Food and Drug Administration Public Workshop Summary-Addressing Challenges in Inhaled Antifungal Drug Development.
Caroline J Jjingo, Shukal Bala, Ursula Waack, Mark Needles, Timothy J Bensman
Clinical Infectious Diseases. 2024-06-14
T-cells and precision medicine for allergic bronchopulmonary aspergillosis.
Richard B Moss
The European Respiratory Journal. 2024-05-01
129 citations
Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses.
Ritesh Agarwal, Inderpaul Singh Sehgal, Valliappan Muthu, David W Denning, Arunaloke Chakrabarti
The European Respiratory Journal. 2024-04-01

Journal Articles

Prolonged corticosteroid therapy in cystic fibrosis.
Lewiston NJ, Moss RB, CF Club Abstr 22:131
IgM and IgG rheumatoid factors in cystic fibrosis compared to rheumatic diseases of childhood and controls.
Moss RB, Hsu YP, Clin Res 30:96A
Autoimmunity in cystic fibrosis: evidence against polyclonal B cell activation.
Moss RB, Hsu YP, J Allergy Clin Immunol 69:S112

Books/Book Chapters

Bronchial Asthma. Principles of Diagnosis and Treatment.
Chapter: Differential diagnosis of asthma in children
Page 141 - 169Moss RBEditors: Gershwin ME and Halpern GM.The Humana Press Inc., Totowa NJEdition 3rd,
Johns Hopkins Advanced Studies in Medicine 10.
Chapter: Cystic fibrosis: pathophysiology and therapeutic Targets
Page 9 - 13. Moss RBEditors: Ahead of the Curve – Emerging CF Therapies.
Pediatr Pulmonol 44: Suppl 32.
Chapter: Practicalities of ABPA diagnosis and treatment
Page 201 - 202Moss RB

Abstracts/Posters

Treatment of Early Pseudomonoas Aeruginosa Infection – When and How.
Moss RB, Dannemiller Memorial Educational Foundation CME Faculty, Los Angeles CA
Atopy in Asthma: Making the Pieces Fit in Clinical Practice
Moss RB, with Richard J.Martin MD, Postgraduate Institute of Medicine/Respiratory & Allergic Disease Foundation CME Teleconference
Childhood asthma.
Moss RB, Pediatric Grand Rounds, Community Hospital of Monterey Peninsula,Monterey CA

Lectures

Current Status of Early Treatment for CF Lung Infection.
Montreal Children's Hospital-McGill University, Montreal Canada
Cystic Fibrosis Quality Care for Quality Outcomes.
Children’s Hospital, Columbus
CF Lung Disease: Is There a Threshold for Intervention?
University of Wisconson, Madison WI - 11/10/2005; West Palm Beach FL

Other

BioMedNet Biofeedback Interview.
Moss RB, HMS Beagle vol 63
http://news.bmn.com/hmsbeagle/63/notes/biofeed
Cystic fibrosis: new insights and treatments.
Moss RB, Hospital Practice 36:25-37
http://www.hosppract.com/issues/2001/01/moss.htm
Gene therapy for cystic fibrosis: the rise and fall of a viral vector.
Moss RB, US Respiratory Disease, 40-41
http://www.touchbriefings.com/download.cfm?fileID=9161